Investor Presentaiton
Respiratory diagnostics are failing us
Spirometry: 1846
1D technology
Accurate but insensitive
20% market
CT: 1971
3D technology
Sensitive, but expensive and
high radiation dose
11% market
EME SPIROMET
4DMedical™
X-ray: 1895
2D technology
Inexpensive, but tells us very
little about airflow
67% market
Cost
USD $120 (Average estimated)
71
Advantages
2-dimensional scan; Ubiquitous; Relatively inexpensive;
Low radiation dosage (0.1 mSv)
n and
Limitations
⚫ Measures structure rather than function
cant
• Limited clinical value
•Overlapping anatomy means features can be hidden
and be missed
• Poor record in screening applications
These four technologies account for 99% of the 382 million respiratory diagnostics test
performed per annum globally
4DMedical Limited (ASX:4DX) Investor Presentation | September 2022
9View entire presentation